Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.500 | 1.500 | 0.000 |
Shares | 98.500 | 98.500 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.520 | 17.939 |
Price to Book | 3.043 | 2.970 |
Price to Sales | 2.935 | 2.162 |
Price to Cash Flow | 13.927 | 12.180 |
Dividend Yield | 1.908 | 2.060 |
5 Years Earnings Growth | 14.143 | 11.266 |
Name | Net % | Category Average |
---|---|---|
Industrials | 18.290 | 11.700 |
Healthcare | 17.500 | 13.839 |
Financial Services | 17.470 | 15.824 |
Technology | 15.320 | 23.255 |
Consumer Defensive | 8.790 | 7.847 |
Basic Materials | 8.030 | 4.267 |
Consumer Cyclical | 7.540 | 10.529 |
Communication Services | 5.870 | 7.532 |
Real Estate | 1.190 | 2.833 |
Number of long holdings: 90
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Visa A | US92826C8394 | 2.72 | 311.82 | -0.44% | |
Schneider Electric | FR0000121972 | 2.55 | 239.05 | -0.54% | |
Thermo Fisher Scientific | US8835561023 | 2.38 | 512.98 | -0.24% | |
Medtronic | IE00BTN1Y115 | 2.37 | 85.68 | -0.08% | |
Charles Schwab | US8085131055 | 2.21 | 82.25 | +0.59% | |
Willis Towers Watson | IE00BDB6Q211 | 2.16 | 316.65 | +0.64% | |
Alphabet A | US02079K3059 | 2.05 | 169.12 | +0.88% | |
Roche Holding Participation | CH0012032048 | 2.04 | 251.40 | -0.83% | |
Oracle | US68389X1054 | 1.97 | 190.37 | +1.27% | |
Comcast | US20030N1019 | 1.97 | 42.64 | -1.30% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
MFS Investment Funds Global GBP | 633.71M | 4.63 | 3.11 | 10.66 | ||
MFS Global Concentrated Equity Fucg | 130.99M | 5.68 | 2.46 | 10.93 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review